{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:23:58Z","timestamp":1789399438089,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Ovarian stimulation with gonadotropins is crucial for obtaining mature oocytes for in vitro fertilization (IVF). Determining the optimal gonadotropin dosage is essential for maximizing its effectiveness. Our study aimed to develop a machine learning (ML)\u00a0model to predict oocyte counts in IVF patients and retrospectively analyze whether higher gonadotropin doses improve ovarian stimulation outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed the data from 9598 ovarian stimulations. An ML model was employed to predict the number of mature metaphase II (MII) oocytes based on clinical parameters. These predictions were compared with the actual counts of retrieved MII oocytes at different gonadotropin dosages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The ML model provided precise predictions of MII counts, with the AMH and AFC being the most important, and the previous stimulation outcome and age, the less important features for the prediction. Our findings revealed that increasing gonadotropin dosage did not result in a higher number of retrieved MII oocytes. Specifically, for patients predicted to produce 4\u20138 MII oocytes, a decline in oocyte count was observed as gonadotropin dosage increased. Patients with low (1\u20133) and high (9\u201312) MII predictions achieved the best results when administered a daily dose of 225\u00a0IU; lower and higher doses proved to be less effective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study suggests that high gonadotropin doses do not enhance MII oocyte retrieval. Our ML model can offer clinicians a novel tool for the precise prediction of MII to guide gonadotropin dosing.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10815-024-03102-z","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T06:01:46Z","timestamp":1712210506000},"page":"1557-1567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring gonadotropin dosing effects on MII oocyte retrieval in ovarian stimulation"],"prefix":"10.1007","volume":"41","author":[{"given":"Krystian","family":"Zieli\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5168-0232","authenticated-orcid":false,"given":"Anna","family":"Kloska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wygocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Ziele\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kunicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"3102_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fendo.2019.00181","volume":"10","author":"FJ Broekmans","year":"2019","unstructured":"Broekmans FJ. Individualization of FSH doses in assisted reproduction: facts and fiction. Front Endocrinol (Lausanne). 2019;10:181. https:\/\/doi.org\/10.3389\/fendo.2019.00181.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"3102_CR2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616\u201324. https:\/\/doi.org\/10.1093\/humrep\/der092.","journal-title":"Hum Reprod."},{"key":"3102_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.rbmo.2013.05.015","volume":"27","author":"JD Stanger","year":"2013","unstructured":"Stanger JD, Yovich JL. Follicle recruitment determines IVF productivity rate via the number of embryos frozen and subsequent transfers. Reprod Biomed Online. 2013;27:286\u201396. https:\/\/doi.org\/10.1016\/j.rbmo.2013.05.015.","journal-title":"Reprod Biomed Online."},{"key":"3102_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","volume":"101","author":"RG Steward","year":"2014","unstructured":"Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101:967\u201373. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.026.","journal-title":"Fertil Steril"},{"key":"3102_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humrep\/dev316","volume":"31","author":"P Drakopoulos","year":"2016","unstructured":"Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, et al. Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31:370\u20136. https:\/\/doi.org\/10.1093\/humrep\/dev316.","journal-title":"Hum Reprod."},{"key":"3102_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/humrep\/des389","volume":"28","author":"HM Fatemi","year":"2013","unstructured":"Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod. 2013;28:442\u201352. https:\/\/doi.org\/10.1093\/humrep\/des389.","journal-title":"Hum Reprod"},{"key":"3102_CR7","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1093\/humrep\/det303","volume":"28","author":"J Ji","year":"2013","unstructured":"Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Hum Reprod. 2013;28:2728\u201334. https:\/\/doi.org\/10.1093\/humrep\/det303.","journal-title":"Hum Reprod"},{"key":"3102_CR8","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26:1768\u201374. https:\/\/doi.org\/10.1093\/humrep\/der106.","journal-title":"Hum Reprod"},{"key":"3102_CR9","doi-asserted-by":"publisher","first-page":"e0149615","DOI":"10.1371\/journal.pone.0149615","volume":"11","author":"G Griesinger","year":"2016","unstructured":"Griesinger G, Verweij PJM, Gates D, Devroey P, Gordon K, Stegmann BJ, et al. Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH Antagonist Protocol. PLoS One. 2016;11:e0149615. https:\/\/doi.org\/10.1371\/journal.pone.0149615.","journal-title":"PLoS One."},{"key":"3102_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113\u201330. https:\/\/doi.org\/10.1093\/humupd\/dmp036.","journal-title":"Hum Reprod Update."},{"key":"3102_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","volume":"20","author":"A La Marca","year":"2014","unstructured":"La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20:124\u201340. https:\/\/doi.org\/10.1093\/humupd\/dmt037.","journal-title":"Hum Reprod Update."},{"key":"3102_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-M\u00fcllerian hormone in women. Hum Reprod Update. 2014;20:370\u201385. https:\/\/doi.org\/10.1093\/humupd\/dmt062.","journal-title":"Hum Reprod Update."},{"key":"3102_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","volume":"119","author":"A La Marca","year":"2012","unstructured":"La Marca A, Papaleo E, Grisendi V, Argento C, Giulini S, Volpe A. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. BJOG. 2012;119:1171\u20139. https:\/\/doi.org\/10.1111\/j.1471-0528.2012.03412.x.","journal-title":"BJOG."},{"key":"3102_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/AOG.0b013e3182116bc8","volume":"117","author":"AZ Steiner","year":"2011","unstructured":"Steiner AZ, Herring AH, Kesner JS, Meadows JW, Stanczyk FZ, Hoberman S, et al. Antim\u00fcllerian hormone as a predictor of natural fecundability in women aged 30\u201342 years. Obstet Gynecol. 2011;117:798\u2013804. https:\/\/doi.org\/10.1097\/AOG.0b013e3182116bc8.","journal-title":"Obstet Gynecol"},{"key":"3102_CR15","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R. Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy. Human Reprod. 2007;22:2414\u201321. https:\/\/doi.org\/10.1093\/humrep\/dem204.","journal-title":"Human Reprod"},{"key":"3102_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40268-016-0126-z","volume":"16","author":"TH Rose","year":"2016","unstructured":"Rose TH, R\u00f6shammar D, Erichsen L, Grundemar L, Ottesen JT. Characterisation of population pharmacokinetics and endogenous follicle-stimulating hormone (FSH) levels after multiple dosing of a recombinant human FSH (FE 999049) in healthy women. Drugs R D. 2016;16:165\u201372. https:\/\/doi.org\/10.1007\/s40268-016-0126-z.","journal-title":"Drugs R D."},{"key":"3102_CR17","doi-asserted-by":"publisher","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","volume":"6","author":"TW Kelsey","year":"2011","unstructured":"Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB. A validated model of serum anti-M\u00fcllerian hormone from conception to menopause. PLoS One. 2011;6:e22024. https:\/\/doi.org\/10.1371\/journal.pone.0022024.","journal-title":"PLoS One."},{"key":"3102_CR18","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2012-1440","volume":"97","author":"S Lie Fong","year":"2012","unstructured":"Lie Fong S, Visser JA, Welt CK, de Rijke YB, Eijkemans MJC, Broekmans FJ, et al. Serum anti-M\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012;97:4650\u20135. https:\/\/doi.org\/10.1210\/jc.2012-1440.","journal-title":"J Clin Endocrinol Metab."},{"key":"3102_CR19","doi-asserted-by":"publisher","first-page":"263349412110242","DOI":"10.1177\/26334941211024203","volume":"15","author":"L Boudry","year":"2021","unstructured":"Boudry L, Racca A, Tournaye H, Blockeel C. Type and dose of gonadotropins in poor ovarian responders: does it matter? Ther Adv Reprod Health. 2021;15:26334941211024203. https:\/\/doi.org\/10.1177\/26334941211024203.","journal-title":"Ther Adv Reprod Health."},{"key":"3102_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.fertnstert.2015.07.1151","volume":"104","author":"VL Baker","year":"2015","unstructured":"Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril. 2015;104:1145\u201352.e552. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.07.1151.","journal-title":"Fertil Steril."},{"key":"3102_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s10815-021-02179-0","volume":"38","author":"ZL Clark","year":"2021","unstructured":"Clark ZL, Thakur M, Leach RE, Ireland JJ. FSH dose is negatively correlated with number of oocytes retrieved: analysis of a data set with ~650,000 ART cycles that previously identified an inverse relationship between FSH dose and live birth rate. J Assist Reprod Genet. 2021;38:1787\u201397. https:\/\/doi.org\/10.1007\/s10815-021-02179-0.","journal-title":"J Assist Reprod Genet."},{"key":"3102_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.986438","volume":"13","author":"X Luo","year":"2022","unstructured":"Luo X, Pei L, He Y, Li F, Han W, Xiong S, et al. High initial FSH dosage reduces the number of available cleavage-stage embryos in a GnRH-antagonist protocol: Real-world data of 8,772 IVF cycles from China. Front Endocrinol (Lausanne). 2022;13:986438. https:\/\/doi.org\/10.3389\/fendo.2022.986438.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"3102_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.fertnstert.2016.01.022","volume":"105","author":"E Bosch","year":"2016","unstructured":"Bosch E, Labarta E, Kolibianakis E, Rosen M, Meldrum D. Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertil Steril. 2016;105:560\u201370. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.01.022.","journal-title":"Fertil Steril."},{"key":"3102_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/jcm10061211","volume":"10","author":"L-T Lin","year":"2021","unstructured":"Lin L-T, Tsui K-H. The relationships between serum DHEA-S and AMH levels in infertile women: a retrospective cross-sectional study. J Clin Med. 2021;10:1211. https:\/\/doi.org\/10.3390\/jcm10061211.","journal-title":"J Clin Med."},{"key":"3102_CR25","doi-asserted-by":"publisher","first-page":"e1011020","DOI":"10.1371\/journal.pcbi.1011020","volume":"19","author":"K Zieli\u0144ski","year":"2023","unstructured":"Zieli\u0144ski K, Pukszta S, Mickiewicz M, Kotlarz M, Wygocki P, Ziele\u0144 M, et al. Personalized prediction of the secondary oocytes number after ovarian stimulation: a machine learning model based on clinical and genetic data. PLoS Comput Biol. 2023;19:e1011020. https:\/\/doi.org\/10.1371\/journal.pcbi.1011020.","journal-title":"PLoS Comput Biol"},{"key":"3102_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"JH Friedman","year":"2001","unstructured":"Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29:1189\u2013232. https:\/\/doi.org\/10.1214\/aos\/1013203451.","journal-title":"Ann Stat"},{"key":"3102_CR27","unstructured":"Ke G, Meng Q, Finley T, Wang T, Chen W, Ma W, et al. LightGBM: a highly efficient gradient boosting decision tree. In: Proceedings of the 31st international conference on neural information processing systems (NIPS'17). Curran Associates Inc. p. 3149\u201357. https:\/\/proceedings.neurips.cc\/paper_files\/paper\/2017\/file\/6449f44a102fde848669bdd9eb6b76fa-Paper.pdf. Accessed 31 Oct 2023."},{"key":"3102_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2:56\u201367. https:\/\/doi.org\/10.1038\/s42256-019-0138-9.","journal-title":"Nat Mach Intell."},{"key":"3102_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/humrep\/deh663","volume":"20","author":"ER Klinkert","year":"2005","unstructured":"Klinkert ER, Broekmans FJM, Looman CWN, Habbema JDF, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod. 2005;20:611\u20135. https:\/\/doi.org\/10.1093\/humrep\/deh663.","journal-title":"Hum Reprod"},{"key":"3102_CR30","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.fertnstert.2015.08.014","volume":"104","author":"J Lefebvre","year":"2015","unstructured":"Lefebvre J, Antaki R, Kadoch I-J, Dean NL, Sylvestre C, Bissonnette F, et al. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial. Fertil Steril. 2015;104:1419\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.08.014.","journal-title":"Fertil Steril."},{"key":"3102_CR31","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.rbmo.2022.07.010","volume":"45","author":"M Fanton","year":"2022","unstructured":"Fanton M, Nutting V, Rothman A, Maeder-York P, Hariton E, Barash O, et al. An interpretable machine learning model for individualized gonadotrophin starting dose selection during ovarian stimulation. Reprod Biomed Online. 2022;45:1152\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2022.07.010.","journal-title":"Reprod Biomed Online."},{"key":"3102_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.fertnstert.2020.04.027","volume":"114","author":"KL Shaia","year":"2020","unstructured":"Shaia KL, Acharya KS, Harris BS, Weber JM, Truong T, Muasher SJ. Total follicle stimulating hormone dose is negatively correlated with live births in a donor\/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry. Fertil Steril. 2020;114:545\u201351. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.04.027.","journal-title":"Fertil Steril."},{"key":"3102_CR33","doi-asserted-by":"publisher","unstructured":"Luo X, Pei L, He Y, Li F, Han W, Xiong S, et al. High initial FSH dosage reduces the number of available cleavage-stage embryos in a GnRH-antagonist protocol: real-world data of 8,772 IVF cycles from China. Front Endocrinol (Lausanne). 2022;13:986438. https:\/\/doi.org\/10.3389\/fendo.2022.986438","DOI":"10.3389\/fendo.2022.986438"},{"key":"3102_CR34","doi-asserted-by":"publisher","unstructured":"Nargund G, Datta AK, Campbell S, Patrizio P, Chian R-C, Ombelet W, et al. The case for mild stimulation for IVF: recommendations from the international society for mild approaches in assisted reproduction. Reprod Biomed Online. 2022;45(1133\u201344) https:\/\/doi.org\/10.1016\/j.rbmo.2022.07.019.","DOI":"10.1016\/j.rbmo.2022.07.019"},{"key":"3102_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humupd\/dmaa035","volume":"27","author":"AK Datta","year":"2021","unstructured":"Datta AK, Maheshwari A, Felix N, Campbell S, Nargund G. Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis. Hum Reprod Update. 2021;27:229\u201353. https:\/\/doi.org\/10.1093\/humupd\/dmaa035.","journal-title":"Hum Reprod Update."},{"key":"3102_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.rbmo.2022.11.008","volume":"46","author":"IM Magaton","year":"2023","unstructured":"Magaton IM, Helmer A, Eisenhut M, Roumet M, Stute P, von Wolff M. Oocyte maturity, oocyte fertilization and cleavage-stage embryo morphology are better in natural compared with high-dose gonadotrophin stimulated IVF cycles. Reprod Biomed Online. 2023;46:705\u201312. https:\/\/doi.org\/10.1016\/j.rbmo.2022.11.008.","journal-title":"Reprod Biomed Online."},{"key":"3102_CR37","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s10815-021-02220-2","volume":"38","author":"DC Gonullu","year":"2021","unstructured":"Gonullu DC, McCulloh DH, Robinson LG, Oh C, Keefe DL. Oocyte stimulation parameters influence the number and proportion of mature oocytes retrieved in assisted reproductive technology cycles. J Assist Reprod Genet. 2021;38:2283\u20139. https:\/\/doi.org\/10.1007\/s10815-021-02220-2.","journal-title":"J Assist Reprod Genet."},{"key":"3102_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/humupd\/dmy019","volume":"24","author":"C Alviggi","year":"2018","unstructured":"Alviggi C, Conforti A, Santi D, Esteves SC, Andersen CY, Humaidan P, et al. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis. Hum Reprod Update. 2018;24:599\u2013614. https:\/\/doi.org\/10.1093\/humupd\/dmy019.","journal-title":"Hum Reprod Update."},{"key":"3102_CR39","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/genes14061269","volume":"14","author":"C Alviggi","year":"2023","unstructured":"Alviggi C, Longobardi S, Papaleo E, Santi D, Alfano S, Vanni VS, et al. Genetic variants of gonadotropins and their receptors could influence controlled ovarian stimulation: IVF data from a prospective multicenter study. Genes (Basel). 2023;14:1269. https:\/\/doi.org\/10.3390\/genes14061269.","journal-title":"Genes (Basel)."},{"key":"3102_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fendo.2019.00387","volume":"10","author":"A Conforti","year":"2019","unstructured":"Conforti A, Esteves SC, Cimadomo D, Vaiarelli A, Di Rella F, Ubaldi FM, et al. Management of women with an unexpected low ovarian response to gonadotropin. Front Endocrinol (Lausanne). 2019;10:381. https:\/\/doi.org\/10.3389\/fendo.2019.00387.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"3102_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.797365","volume":"12","author":"A Conforti","year":"2022","unstructured":"Conforti A, T\u00fcttelmann F, Alviggi C, Behre HM, Fischer R, Hu L, et al. Effect of genetic variants of gonadotropins and their receptors on ovarian stimulation outcomes: a Delphi consensus. Front Endocrinol (Lausanne). 2022;12:797365. https:\/\/doi.org\/10.3389\/fendo.2021.797365.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"3102_CR42","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00404-013-3132-1","volume":"289","author":"B Vural","year":"2014","unstructured":"Vural B, Cakiroglu Y, Vural F, Filiz S. Hormonal and functional biomarkers in ovarian response. Arch Gynecol Obstet. 2014;289:1355\u201361. https:\/\/doi.org\/10.1007\/s00404-013-3132-1.","journal-title":"Arch Gynecol Obstet."},{"key":"3102_CR43","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00404-014-3332-3","volume":"290","author":"E Tsakos","year":"2014","unstructured":"Tsakos E, Tolikas A, Daniilidis A, Asimakopoulos B. Predictive value of anti-M\u00fcllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF\/ET. Arch Gynecol Obstet. 2014;290:1249\u201353. https:\/\/doi.org\/10.1007\/s00404-014-3332-3.","journal-title":"Arch Gynecol Obstet."},{"key":"3102_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7827-10-32","volume":"10","author":"K Fiedler","year":"2012","unstructured":"Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reproductive Biology and Endocrinology. 2012;10:32. https:\/\/doi.org\/10.1186\/1477-7827-10-32.","journal-title":"Reproductive Biology and Endocrinology."}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-024-03102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-024-03102-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-024-03102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T09:11:33Z","timestamp":1720084293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-024-03102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["3102"],"URL":"https:\/\/doi.org\/10.1007\/s10815-024-03102-z","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"2 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have read the journal\u2019s policy and declare the following competing interests: K.Z., A.K., and M.K. are employees of INVICTA, clinics and medical laboratories for infertility treatment; P.W. and M.Z. are employees of MIM Solutions. The affiliation does not impact the authors\u2019 impartiality, adherence to journal standards and policies, or the availability of data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}